norketamine has been researched along with Kidney Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armelloni, S; Berra, S; Carraro, M; Corbelli, A; Giardino, L; Guerrot, D; Ikehata, M; Li, M; Mattinzoli, D; Messa, P; Rastaldi, MP; Tourrel, F; Zennaro, C | 1 |
1 other study(ies) available for norketamine and Kidney Diseases
Article | Year |
---|---|
Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier.
Topics: Animals; Cells, Cultured; Cytoskeleton; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Exocytosis; Female; Glomerular Filtration Rate; Glutamic Acid; Ketamine; Kidney Diseases; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Knockout; Podocytes; rab3A GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2009 |